CN109402051A - A kind of human umbilical cord mesenchymal stem cells serum free medium - Google Patents
A kind of human umbilical cord mesenchymal stem cells serum free medium Download PDFInfo
- Publication number
- CN109402051A CN109402051A CN201811621520.9A CN201811621520A CN109402051A CN 109402051 A CN109402051 A CN 109402051A CN 201811621520 A CN201811621520 A CN 201811621520A CN 109402051 A CN109402051 A CN 109402051A
- Authority
- CN
- China
- Prior art keywords
- umbilical cord
- stem cells
- serum free
- mesenchymal stem
- cord mesenchymal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Abstract
The present invention provides a kind of human umbilical cord mesenchymal stem cells serum free mediums, it is characterized by comprising α-MEM basal mediums, it also comprises the following components: with final concentration, the instant proteoglycan 1-50mg/mL of glutamine 1-20mM, HEPEs 1-20mM, 10-100 μM of putrescine, 0.1-10 μM of transferrins, 10-400 μM of vitamin C, 1-10 μM of Recombulin, progesterone 1-20nM, cortisol 10-200nM, human serum albumin 1-20mg/mL, basic fibroblast growth factor 1-10ng/mL, transforminggrowthfactor-β1 1-10ng/mL, spirulina.Human umbilical cord mesenchymal stem cells serum free medium provided by the invention is remarkably improved the multiplication rate and adherent performance of human umbilical cord mesenchymal stem cells, be conducive to the proliferation of human umbilical cord mesenchymal stem cells and the holding of stem cell properties, have into rouge, Osteoinductive differentiation potential.Medium component is simple, clear, stable, is free of any serum component, overcomes the danger of foreign protei pollution and pathogenic microorganisms, highly-safe.
Description
Technical field
The invention belongs to technical field of stem cell culture, and in particular to a kind of human umbilical cord mesenchymal stem cells free serum culture
The formula of base and its application.
Background technique
It is mesoblastic thin at soma that mescenchymal stem cell (Mesenchymal Stem Cells, MSCs) is derived from early stage
Born of the same parents have height self-renewal capacity and multi-lineage potential, are the important cell components of one of hematopoieticmicroenviron-ment, can be with
To Various Tissues such as bone, cartilage, muscle, ligament, tendon, fat and stromal cell proliferation differentiation, and immunogenicity is weak, is group
Knit the seed cell source of Project.Human umbilical cord mesenchymal stem cells (human umbilical cord mesenchymal
Stem cells, hUC-MSCs) the magnificent Tong Shi glue in the neonatal umbilical cord also has in addition to all characteristics with MSCs
There is rich content, cell is pure, and immunogenicity is lower, and cell is original, differentiation capability is stronger, and the advantages such as no ethics limitation can be
The cell origin of experiment and clinical offer abundance, has wide potential applicability in clinical practice.
The existing culture medium for cultivating hUC-MSCs is broadly divided into three classes.One kind is that animal is added in basal medium
Serum, drawback are the alloplasms that can not evade in animal blood serum, it is understood that there may be human body foreign protei pollution or allergy, risk compared with
Greatly；Second class is the serum substitute of human blood platelets lysate etc to be added in basal medium, but equally have ingredient unknown
Albumen exist, the disadvantages of batch wise differences are larger, and source is unstable.Third class is to add chemical constituent in basal medium to define
Blood serum substituting ingredient, this had not only met the fostering requirement of hUC-MSCs, but effectively prevent preceding two classes culture medium it is many not
Sharp factor.Therefore, the cell culture medium for being suitble to the chemical formulation of hUC-MSCs cell growth to determine is that stem cell moves towards clinical
Essential condition.
However, the commercialization MSCs serum free medium sold on the market at present, either external import or state
Interior development & production, not only expensive, the effect of cell culture is also undesirable.Compared with serum free culture system system cell state it is poor,
Cell adherence quality is poor, cumbersome, cell proliferation rate is inadequate, and cell senescence speed is fast, and the differentiation capability of MSCs reduces.
Summary of the invention
To solve problems of the prior art, inventor obtains a kind of new people by experimental verification repeatedly
Umbilical cord mesenchymal stem cells serum free medium can effectively cultivate umbilical cord mesenchymal stem cells.
Human umbilical cord mesenchymal stem cells serum free medium provided by the present invention is using α-MEM basal medium, also
Including following component and its concentration: glutamine 1-20mM, HEPEs 1-20mM, 10-100 μM of putrescine, transferrins 0.1-10 μ
M, 10-400 μM of vitamin C, 1-10 μM of insulin, progesterone 1-20nM, cortisol 10-200nM, human serum albumin 1-20mg/
ML, basic fibroblast growth factor 1-10ng/mL, transforming growth factor 1-10ng/mL, instant proteoglycan 1-50mg/
mL。
The instant proteoglycan is a kind of water-soluble polysaccharide extracted from spirulina, is a kind of nontoxic natural life
Active substances have and promote cell growth, improve immunity, antitumor, anti-radiation, anti-oxidant, anti-aging, to endonuclease
Enzymatic activity and DNA, which repair synthesis, the functions such as humidification.
The instant proteoglycan, preparation method are as follows: spirulina powder being cleaned, is added after water at 75-90 DEG C
Heating, then is cooled to room temperature, is filtered under diminished pressure separation, with hydrochloric acid adjusting filtrate pH value to 3-5, places 12-36h, 4000rpm,
It is centrifuged 15min centrifugation；Isolated supernatant Na2CO3Solution adjusts pH to 7.0, is then spray-dried, obtains algae albumen
Polyoses extract.
Preferably, a kind of human umbilical cord mesenchymal stem cells serum free medium provided by the invention, including the training of the basis α-MEM
Base is supported, is also comprised the following components and its concentration: glutamine 5mM, HEPEs 7mM, 60 μM of putrescine, 1 μM of transferrins, vitamin
200 μM of C, 6 μM of insulin, progesterone 20nM, cortisol 110nM, human serum albumin 6mg/mL, basic fibroblast growth
Factor 2ng/mL, transforming growth factor 4ng/mL, instant proteoglycan 5mg/mL.
Preferably, the insulin is Recombulin, and the transforming growth factor is transforming growth factor-beta 1, described
Instant proteoglycan derives from spirulina.
Correspondingly, the present invention also provides the preparation method of human umbilical cord mesenchymal stem cells serum free medium, including it is as follows
Step: into α-MEM basal medium, by the concentration be added glutamine, HEPEs, putrescine, transferrins, vitamin C,
Insulin, progesterone, cortisol, human serum albumin, basic fibroblast growth factor, transforming growth factor, instant albumen
Polysaccharide mixes, through 0.2 μm of membrane filtration degerming, obtains the serum free medium of human umbilical cord mesenchymal stem cells.
Compared with prior art, it is trained using the human umbilical cord mesenchymal stem cells serum free medium that above technical scheme is prepared
Umbilical cord mesenchymal stem cells are supported, are had the advantage that
1. because without the serum for adding animal origin, it is possible to control the risk of infection；
2. component contained by is all from recombinant protein or chemical synthesis, human immunity will not be caused to repel；
3. it is easy to operate, it does not need in advance to be coated with culture dish or culture bottle；
4. cell adherence quality is good, cellular morphology is good；
5. cell proliferation rate is high, stem cell properties keep good.
Detailed description of the invention
The human umbilical cord mesenchymal stem cells of tri- kinds of different culture mediums (A, B, C) of Fig. 1 culture are to the comparison diagram (P3 generation) converged；
The comparison diagram of the human umbilical cord mesenchymal stem cells growth curve of tri- kinds of different culture mediums (A, B, C) of Fig. 2 culture；
The P5 of tri- kinds of different culture mediums (A, B, C) of Fig. 3 culture breaks up dye for the adipogenic induction of human umbilical cord mesenchymal stem cells
Color result figure；
The P5 of tri- kinds of different culture mediums (A, B, C) of Fig. 4 culture is contaminated for the Osteoinductive differentiation of human umbilical cord mesenchymal stem cells
Color result figure；
Wherein: A culture medium is the FBS (Gibco) of+10% percent by volume of DMEM-LG basal medium；
B culture medium is+10% platelet lysates liquid of α-MEM basal medium
C culture medium is the human umbilical cord mesenchymal stem cells serum free medium provided in embodiment 1.
Specific implementation method
The present invention is described in further details with reference to the accompanying drawings and examples.
Conventional commercial product can be selected in each component in the present invention, such as progesterone is purchased from sigma, article No. V900699.
The screening of 1 human umbilical cord mesenchymal stem cells serum free medium of embodiment proportion
Preparation method: into α-MEM basal medium, glutamine mother liquor, HEPEs mother liquor, corruption is added by the concentration
Amine, transferrins mother liquor, vitamin C mother liquor, insulin mother liquor, progesterone mother liquor, cortisol mother liquor, human serum albumin mother liquor,
Basic fibroblast growth factor mother liquor, transforming growth factor mother liquor, instant proteoglycan mother liquor, stir and evenly mix, through 0.2 μm
Membrane filtration degerming to obtain the final product.
Glutamine mother liquor: taking 0.5g, is dissolved with tri-distilled water, is made into the mother liquor of 200mM, -20 DEG C of preservations.Recombination turns iron egg
The preparation of white mother liquor: taking 50mg, is dissolved with α-MEM basal medium, is made into the mother liquor of 1mM, -20 DEG C of preservations.Vitamin C mother liquor
Preparation: take 1g, dissolved with α-MEM basal medium, be made into the mother liquor of 50mg/ml, -20 DEG C of preservations.Rh-insulin is female
The preparation of liquid: taking 20mg, with the dissolving with hydrochloric acid of pH3, is made into the mother liquor of 1mg/ml, -20 DEG C of preservations.The preparation of progesterone mother liquor:
5g is taken, is dissolved with ethyl alcohol, the mother liquor of 1mM, -20 DEG C of preservations are made into.The preparation of basic fibroblast growth factor mother liquor: 10 are taken
μ g, is dissolved with PBS, is made into the mother liquor of 10 μ g/ml, -20 DEG C of preservations.The preparation of transforming growth factor mother liquor: taking 2 μ g, molten with PBS
Solution is made into the mother liquor of 2 μ g/ml, -20 DEG C of preservations.
The extraction of instant proteoglycan: spirulina powder 1kg 1L water being rinsed, is filtered, and 10L water is added into filter residue and stirs
It mixes, 1h is heated at 88 DEG C and is filtered under diminished pressure separation after cooling after room temperature, with hydrochloric acid adjusting filtrate pH value to 3.8, stand overnight,
4000rpm is centrifuged 15min, separates the supernatant Na of acquisition2CO3Solution adjusts pH to 7, is then spray-dried, obtains algae albumen
Polyoses extract crude product (pale yellow powder, it is nontoxic, water-soluble) 200g, measuring proteoglycan content in extract is
72.3%.
Following orthogonal test is designed, to transforming growth factor, people's blood in human umbilical cord mesenchymal stem cells serum free medium
Albumin, instant proteoglycan proportion screened, the human umbilical cord mesenchymal that passes on after P3 generation recovery is used in screening process
Stem cell, detailed design are shown in Table 1.
1 Orthogonal Experiment and Design of table probes into the proportion of human umbilical cord mesenchymal stem cells serum free medium
As a result, it has been found that: the human umbilical cord mesenchymal of human umbilical cord mesenchymal stem cells serum free medium, following proportion culture is dry
Cellular morphology, proliferation are best.The culture medium includes α-MEM basal medium, is also comprised the following components and its concentration: glutamine
5mM, HEPEs 7mM, 60 μM of putrescine, 1 μM of transferrins, 200 μM of vitamin C, 6 μM of insulin, progesterone 20nM, cortisol
110nM, human serum albumin 6mg/mL, basic fibroblast growth factor 2 ng/mL, transforming growth factor 4ng/mL, instant egg
White polysaccharide 5mg/mL.
The separation of 2 human umbilical cord mesenchymal stem cells of embodiment
The fresh umbilical cord of newborn is taken, is put into the DMEM-LG culture medium 100ml containing 100U/ml mycillin mixed liquor,
It is placed in 4 DEG C~12 DEG C transports；Umbilical cord is handled in hundred grades of Biohazard Safety Equipments, impregnates umbilical cord, soaking time 30s with 75% medicinal alcohol
~60s removes umbilical cord both ends, and interlude is cut into the segment of 1~2cm long, with physiological saline repeated flushing umbilical cord segment, splits,
Artery therein, vein are removed, and removes bloodstain with physiological saline repeated flushing, is shredded to 2mm3.The tissue block shredded is equal
Even is put in 150mm Tissue Culture Dish (1 block of tissue block solid of every 1~1.5 square centimeter of placement), stands in safety cabinet
10min (air-dries the liquid between culture dish and tissue block), and culture dish inversion is put in 37 DEG C, 5%CO later2, saturation it is wet
Then 1h (being adsorbed in tissue block on culture dish) in the cell incubator of degree uses A culture medium, B culture medium and C culture medium respectively
Culture, and so on repeat to pass on up to a large amount of human umbilical cord mesenchymal stem cells.Fig. 1 is the P3 of three kinds of different culture medium cultures
For human umbilical cord mesenchymal stem cells to the comparison diagram converged.It can be seen from the figure that the cell of three kinds of culture medium cultures is in shuttle
Shape, at fiber-like, but the cell under C culture medium culture, significantly at fiber-like, cell is grown in swirl shape.
The expression of 3 Flow cytometry cell surface marker of embodiment
The P3 cultivated in Example 2 with three kinds of culture mediums (A, B, C) is for human umbilical cord mesenchymal stem cells, to cell fusion
When to 90%, cell is collected in digestion, is washed 2 times with PBS, be separately added into CD44, CD73 with fluorescent marker, CD90,
CD105, CD34, CD45 and HLA-DR surface antibody are incubated for 30min, then are washed 2 times with PBS, thin using flow cytomery
The expression of cellular surface label, the results are shown in Table 2.
The expression of 2 cell surface marker of table
It can be obtained from table 2, the P3 of three kinds of culture mediums (A, B, C) culture is for human umbilical cord mesenchymal stem cells surface markers albumen
Meet the biological characteristics of MSCs.
Influence of the 4 three kinds of culture mediums of embodiment to human umbilical cord mesenchymal stem cells proliferative capacity
Disappeared for human umbilical cord mesenchymal stem cells with 0.125% trypsase in Example 2 with the P3 of culture medium A culture
It is centrifuged after change, is washed twice with PBS later, then be resuspended count with culture medium A, B, C respectively, by 1 × 104A/ml is inoculated into 24 holes
In plate, the hole 1ml/, per the average value of every hole cell total amount of the 2 holes digestion calculated separately under every kind of culture medium culture for 24 hours, often
48h carries out changing liquid to the hole of remaining no count.Continuous counter 12 days.According to count results, cell Proliferation curve is drawn, is such as schemed
Shown in 2.As shown in Figure 2, culture medium C (culture medium of the present invention) is compared with two kinds of culture mediums of A, B, and the cell of the culture adherent time is more
Short, faster, proliferative cell sum is more for growth rate.Culture medium A and culture medium B peak in the 6th, 7 born length respectively, the
8, start to become feeble and die within 9 days, and culture medium C peaked at the 8th day, the 10th talent starts to become feeble and die, the cell Proliferation of three kinds of culture mediums
Sum is also the most of culture medium C.It can be seen that the cell proliferation rate of culture medium culture of the present invention is high, cell Proliferation number
It is more.
Influence of the 5 three kinds of culture mediums of embodiment to human umbilical cord mesenchymal stem cells degree of sticking
The P3 that three kinds of culture mediums (A, B, C) are cultivated in Example 2 adjusts density for cell with 2 × 105A/hole inoculation
Into 6 orifice plates, and corresponding culture medium A, culture medium B, culture medium C being added respectively and is cultivated, cell growth converges to 85%
For use.Respectively with PBS dissolution fibronectin (Fn) and bovine serum albumin(BSA) (BSA) to concentration 100 μ g/ml and 10mg/ml,
4 DEG C of preservations.Every hole adds 500 μ l Fn to be coated with 12 orifice plates, and 4 DEG C overnight.It inhales and abandons Fn, every hole adds 500 μ l 1%BSA, 4 DEG C of closing 2h.
Stand-by three groups of cells are digested into collection respectively, adjustment density is 4 × 10412 orifice plates are added by every hole 1ml cell suspension in a/ml.
It is placed in incubator to continue to be incubated for 3h, the fixed 10min of 4% paraformaldehyde, 0.1% violet staining liquid dyes 10min, and single steaming water is de-
Color 3 times, room temperature is dried.Every group sets 3 multiple holes, and every hole takes 2 visuals field, using 6 software collection picture of Image pro plus
Carry out cell count.It the results are shown in Table 2.As can be known from Table 3, three kinds of culture mediums are respectively to the adhesion effect of UC-MSCs: culture medium
C > culture medium A > culture medium B.
The influence (a) that 3 three kinds of culture mediums of table stick UC-MSCs
| Grouping | It repeats (N) | Cell number |
| Culture medium A | 6 | 129±7.28* |
| Culture medium B | 6 | 102±6.44 |
| Culture medium C | 6 | 142±3.88** |
The adipogenic induction differentiation potential of the human umbilical cord mesenchymal stem cells of 6 three kinds of culture medium cultures of embodiment
The P5 that three kinds of culture mediums (A, B, C) are cultivated in Example 2 is for cell, with 5 × 103A/cm2Density be inoculated in 6
In orifice plate, and corresponding culture medium A, culture medium B, culture medium C are added respectively and is cultivated, it, will when cell confluency is up to 80%
Culture medium is sucked out, and adipogenic induction differential medium (purchased from STEMCELL company, article No. 05412) is added, and changes liquid one every 3 days
It is secondary, after culture 20 days, identify at rouge with oil red O stain liquid kit (being purchased from Suo Laibao company, article No. G1262), as a result
As shown in Figure 3.It can be seen that the cell adipogenic induction differentiation potential that culture medium C provided by the invention is cultivated is more preferably.
The Osteoinductive differentiation potential of the human umbilical cord mesenchymal stem cells of 7 three kinds of culture medium cultures of embodiment
The P5 that three kinds of culture mediums (A, B, C) are cultivated in Example 2 is for cell, with 5 × 103A/cm2Density be inoculated in 6
In orifice plate, and corresponding culture medium A, culture medium B, culture medium C are added respectively and is cultivated, it, will when cell confluency is up to 80%
Culture medium is sucked out, and Osteoinductive differentiation culture medium (purchased from STEMCELL company, article No. 05404) is added, and changes liquid one every 3 days
It is secondary, after culture 28 days, skeletonization identification is carried out with Alizarin red staining liquid, as a result as shown in Figure 4.It can be seen that the present invention provides
The cell Osteoinductive differentiation potential cultivated of culture medium C more preferably.
The above content is a further detailed description of the present invention in conjunction with specific preferred embodiments, and it cannot be said that
Specific implementation of the invention is only limited to these instructions.For those of ordinary skill in the art to which the present invention belongs, exist
Under the premise of not departing from present inventive concept, a number of simple deductions or replacements can also be made, all shall be regarded as belonging to of the invention
Protection scope.
Claims (7)
1. a kind of human umbilical cord mesenchymal stem cells serum free medium, which is characterized in that the serum free medium is to include
α-MEM the basal medium of following density component: glutamine 1-20mM, HEPEs 1-20mM, 10-100 μM of putrescine, turn iron egg
White 0.1-10 μM, 10-400 μM of vitamin C, 1-10 μM of insulin, progesterone 1-20nM, cortisol 10-200nM, the white egg of people's blood
White 1-20mg/mL, basic fibroblast growth factor 1-10ng/mL, transforming growth factor 1-10ng/mL, instant albumen are more
Sugared 1-50mg/mL.
2. serum free medium as described in claim 1, which is characterized in that the preparation method of the instant proteoglycan is such as
Under: spirulina powder is cleaned, heats, then is cooled to room temperature at 75-90 DEG C after adding water, be filtered under diminished pressure separation, use hydrochloric acid
Filtrate pH value is adjusted to 3-5, places 12-36h, 4000rpm, centrifugation 15min centrifugation；Isolated supernatant Na2CO3It is molten
Liquid adjusts pH to 7.0, is then spray-dried, obtains algae protein polyose extract.
3. serum free medium as described in claim 1, which is characterized in that the concentration of each component is such as in the culture medium
Under: glutamine 5mM, HEPEs 7mM, 60 μM of putrescine, 1 μM of transferrins, 200 μM of vitamin C, 6 μM of insulin, progesterone
20nM, cortisol 110nM, human serum albumin 6mg/mL, basic fibroblast growth factor 2 ng/mL, transforming growth factor
4ng/mL, instant proteoglycan 5mg/mL.
4. serum free medium as claimed in claim 1 or 3, which is characterized in that the insulin is Recombulin.
5. serum free medium as claimed in claim 1 or 3, which is characterized in that the transforming growth factor is conversion life
The long factor-β 1.
6. the preparation method of serum free medium described in claim 1 or 3, which is characterized in that be to α-MEM basal medium
In, glutamine, HEPEs, putrescine, transferrins, vitamin C, insulin, progesterone, cortisol, people is added by the concentration
Blood albumin, basic fibroblast growth factor, transforming growth factor, instant proteoglycan mix, through 0.2 μm of filter membrane mistake
Bacterium is filtered out, the serum free medium of human umbilical cord mesenchymal stem cells is obtained.
7. application of the serum free medium described in claim 1 or 3 in culture human umbilical cord mesenchymal stem cells.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811621520.9A CN109402051A (en) | 2018-12-28 | 2018-12-28 | A kind of human umbilical cord mesenchymal stem cells serum free medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811621520.9A CN109402051A (en) | 2018-12-28 | 2018-12-28 | A kind of human umbilical cord mesenchymal stem cells serum free medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109402051A true CN109402051A (en) | 2019-03-01 |
Family
ID=65462504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811621520.9A Pending CN109402051A (en) | 2018-12-28 | 2018-12-28 | A kind of human umbilical cord mesenchymal stem cells serum free medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109402051A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111304163A (en) * | 2019-11-13 | 2020-06-19 | 上海奈康生物科技有限公司 | Large-scale culture method of umbilical cord mesenchymal stem cells |
| CN111494297A (en) * | 2020-04-28 | 2020-08-07 | 青岛麦迪赛斯生物科技有限公司 | Essence containing culture supernatant of human umbilical cord mesenchymal stem cells |
| CN112322581A (en) * | 2020-09-14 | 2021-02-05 | 生物岛实验室 | Composition and application thereof, cell culture medium and recovery method of mesenchymal stem cells |
| CN114480272A (en) * | 2022-02-22 | 2022-05-13 | 张国锋 | Additive and culture medium for umbilical cord mesenchymal stem cell culture and preparation method of additive and culture medium |
| CN114990060A (en) * | 2022-07-20 | 2022-09-02 | 苏州科贝生物技术有限公司 | Method for promoting umbilical cord tissue block to adhere to wall |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102827807A (en) * | 2012-09-19 | 2012-12-19 | 北京京蒙高科干细胞技术有限公司 | Serum-free culture medium for mesenchymal stem cells |
| CN103555665A (en) * | 2013-08-12 | 2014-02-05 | 北京东方华辉生物医药科技有限公司 | SFM (serum-free medium) for culturing MSCs (mesenchymal stem cells) |
| CN104877963A (en) * | 2015-04-15 | 2015-09-02 | 广州赛莱拉干细胞科技股份有限公司 | Serum-free human umbilical cord mesenchymal stem cell culture medium and preparation method thereof |
| CN105112365A (en) * | 2015-08-18 | 2015-12-02 | 广州暨南生物医药研究开发基地有限公司 | Serum-free medium for human umbilical cord mesenchymal stem cells and preparation method thereof |
| CN107043747A (en) * | 2017-06-23 | 2017-08-15 | 王晓柯 | A kind of human umbilical cord mesenchymal stem cells serum free medium |
| CN107354131A (en) * | 2017-08-10 | 2017-11-17 | 河南省银丰生物工程技术有限公司 | A kind of culture medium for umbilical cord mesenchymal stem cells |
| CN108138146A (en) * | 2015-10-20 | 2018-06-08 | 凯尔科迪公司 | The method for preparing primary cell sample |
| CN108251359A (en) * | 2017-12-20 | 2018-07-06 | 上海华新生物高技术有限公司 | A kind of mesenchymal stem cell serum-free culture medium and cultural method |
| CN108795855A (en) * | 2018-06-26 | 2018-11-13 | 吉林省太阳鸟再生医学工程有限责任公司 | A kind of serum free medium of mescenchymal stem cell |
-
2018
- 2018-12-28 CN CN201811621520.9A patent/CN109402051A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102827807A (en) * | 2012-09-19 | 2012-12-19 | 北京京蒙高科干细胞技术有限公司 | Serum-free culture medium for mesenchymal stem cells |
| CN103555665A (en) * | 2013-08-12 | 2014-02-05 | 北京东方华辉生物医药科技有限公司 | SFM (serum-free medium) for culturing MSCs (mesenchymal stem cells) |
| CN104877963A (en) * | 2015-04-15 | 2015-09-02 | 广州赛莱拉干细胞科技股份有限公司 | Serum-free human umbilical cord mesenchymal stem cell culture medium and preparation method thereof |
| CN105112365A (en) * | 2015-08-18 | 2015-12-02 | 广州暨南生物医药研究开发基地有限公司 | Serum-free medium for human umbilical cord mesenchymal stem cells and preparation method thereof |
| CN108138146A (en) * | 2015-10-20 | 2018-06-08 | 凯尔科迪公司 | The method for preparing primary cell sample |
| CN107043747A (en) * | 2017-06-23 | 2017-08-15 | 王晓柯 | A kind of human umbilical cord mesenchymal stem cells serum free medium |
| CN107354131A (en) * | 2017-08-10 | 2017-11-17 | 河南省银丰生物工程技术有限公司 | A kind of culture medium for umbilical cord mesenchymal stem cells |
| CN108251359A (en) * | 2017-12-20 | 2018-07-06 | 上海华新生物高技术有限公司 | A kind of mesenchymal stem cell serum-free culture medium and cultural method |
| CN108795855A (en) * | 2018-06-26 | 2018-11-13 | 吉林省太阳鸟再生医学工程有限责任公司 | A kind of serum free medium of mescenchymal stem cell |
Non-Patent Citations (3)
| Title |
|---|
| 余跃: "《干细胞基础与临床》", 29 February 2008, 中国科学技术大学出版社 * |
| 张所信等: "《精细化工新产品研究与开发》", 31 December 2000, 西北大学出版社 * |
| 温燕梅: "螺旋藻中药用成分的综合提取研究", 《食品科技》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111304163A (en) * | 2019-11-13 | 2020-06-19 | 上海奈康生物科技有限公司 | Large-scale culture method of umbilical cord mesenchymal stem cells |
| CN111494297A (en) * | 2020-04-28 | 2020-08-07 | 青岛麦迪赛斯生物科技有限公司 | Essence containing culture supernatant of human umbilical cord mesenchymal stem cells |
| CN112322581A (en) * | 2020-09-14 | 2021-02-05 | 生物岛实验室 | Composition and application thereof, cell culture medium and recovery method of mesenchymal stem cells |
| CN112322581B (en) * | 2020-09-14 | 2023-05-12 | 生物岛实验室 | Composition and application thereof, cell culture medium and method for recovering mesenchymal stem cells |
| CN114480272A (en) * | 2022-02-22 | 2022-05-13 | 张国锋 | Additive and culture medium for umbilical cord mesenchymal stem cell culture and preparation method of additive and culture medium |
| CN114990060A (en) * | 2022-07-20 | 2022-09-02 | 苏州科贝生物技术有限公司 | Method for promoting umbilical cord tissue block to adhere to wall |
| CN114990060B (en) * | 2022-07-20 | 2023-11-24 | 苏州科贝生物技术有限公司 | Method for promoting adhesion of umbilical cord tissue blocks |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109402051A (en) | A kind of human umbilical cord mesenchymal stem cells serum free medium | |
| KR100908481B1 (en) | Mesenchymal stem cell culture medium and culture method of mesenchymal stem cells using the same | |
| CN106635978B (en) | A kind of umbilical cord mesenchymal stem cells serum free medium and its preparation method and application | |
| US11339372B2 (en) | Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof | |
| CN106906182A (en) | A kind of mesenchymal stem cell serum-free culture medium | |
| WO2016049986A1 (en) | Method for separating umbilical cord mesenchymal stem cells | |
| CN104762260A (en) | Preparation method and application of adipose-derived mesenchymal stem cells and preparation thereof | |
| CN104164403A (en) | Method for extracting and culturing adipose-derived stem cells | |
| CN104805054A (en) | Serum-free medium of stem cell | |
| CN106754675B (en) | A kind of fat stem cell serum free medium and its preparation method and application | |
| US20180362920A1 (en) | Serum-free culture medium and preparation method and application therefor | |
| CN108753708B (en) | A kind of preparation method of Stem Cell Activity factor freeze-dried powder | |
| KR20100065338A (en) | Method for extracting mesenchymal stem cell from human or animal embryo and for extracting the secretion product thereof | |
| CN108300690A (en) | A kind of isolated culture method and serum free medium of fat mesenchymal stem cell | |
| CN107653225A (en) | A kind of culture medium and its amplification method for being used to expand human mesenchymal stem cell | |
| CN105779388B (en) | A kind of culture medium and its cultural method of umbilical cord blood mesenchymal stem cells | |
| CN104480066A (en) | Chondrocyte culture medium and chondrocyte culture method | |
| CN106929470A (en) | It is a kind of for derived mesenchymal stem cells in vitro culture and amplification serum free medium | |
| CN108220230A (en) | A kind of separation of human adipose-derived stem cell and cultural method | |
| CN115011553A (en) | Preparation method and application of stem neural crest-derived bone marrow mesenchymal stem cells | |
| CN104450613A (en) | Cell culture medium beneficial to in-vitro culture of autologous bone marrow mesenchymal stem cells | |
| CN104726401A (en) | Method for improving success rate of umbilical cord blood mesenchymal stem cell culture by using placental mesenchymal stem cells | |
| CN106754657A (en) | A kind of serum free medium of monkey embryonic stem cell | |
| WO2024045404A1 (en) | Bone marrow supernatant and use thereof in cell culture | |
| CN114736851B (en) | Method for preparing vegetable-based fat-cultured meat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |